revance therapeutics

  1. A wrinkle for Allergan; Botox competitor reports positive data

    Revance Therapeutics reports positive data for RT002. http://alph.st/b96326ac A threat to Allergan's Botox, which accounted for 19% of total revenue in Allergan's recently ended quarter.